ICICI Securities recommends these 2 pharma stocks to buy1 min read 04 Apr 2022, 12:05 PM IST
The brokerage and research firm has retained its Buy recommendation on pharma stocks Dr Reddys and JB Chemicals
Novartis AG has entered into agreements with Dr Reddy’s Laboratories (DRL) and JB Chemicals & Pharmaceuticals (JBCPL) for their cardiovascular combination of Valsartan and Sacubitril in India. The patented molecule has been growing at around 38% CAGR over FY19-21 and is one of the fastest growing molecules in the cardiology segment, highlighted domestic brokerage and research firm ICICI Securities.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Select your Category